CClinicalTrials.gg
RecruitingNCT05671588Updated Jan 16, 2024

Cardiovascular Fitness of Patients With Multiple Sclerosis, Effect of Exercise on Fatigue and Depression

An interventional study of Controlled combined exercise group and Conventional rehabilitation in Multiple Sclerosis, sponsored by University Hospital Ostrava. Recruiting at 1 site in Czechia. Open to participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2024-01-16.

Sponsored by University Hospital Ostrava · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 3 months ago, but the record still lists the study as recruiting.
  • Registered 7 months after the study started (first participant enrolled May 2022, registered Dec 2022).
  • Started May 2022; still recruiting 4 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
20 Years to 45 Years
Sex
All
01

Study summary

This study is focused on patients with multiple sclerosis (MS), their cardiovascular fitness, and the effect of combined controlled training on the perception of fatigue, the development of depression, and quality of life in the first year after diagnosis.

Read the detailed description

The main goal is to find out if fatigue, depression, and quality of life depend on the type of training as well as controlled management of newly diagnosed patients. Fatigue is one of the frequent disabling symptoms and the most difficult to influence pharmacologically. It could lead to inactivity and the progression of deconditioning. We know from systematic reviews that aerobic activity leads to improvement in fatigue, however, there are also opinions about exercise intolerance due to disruption of cardiac autonomy control. The investigators will try to determine whether early rehabilitation intervention leads to support and motivation of patients with an incurable chronic neurodegenerative disease to improve the patient condition and contentment. The researchers will focus on effective training by comparing the study group with a control group of patients undergoing conventional rehabilitation versus a protocol-defined controlled combined (aerobic-resistant) exercise program - based on the results of spiroergometry. Both groups will be treated at ambulatory sections by protocol-defined rehabilitation for a 1-hour duration, twice a week for one month, and once a week for the next month (12 therapies in total). The control group will be educated in exercises according to kinesiological analysis to do regularly at home. Finally, the researchers will see if early intervention leads to a change in the active approach of probands.

02

Conditions studied

  • Multiple Sclerosis

Keywords

  • Multiple Sclerosis
  • Controlled combined exercise
  • Cardiovascular fitness
  • Fatigue
  • Depression
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's planned enrollment of 70 is above the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

University Hospital Ostrava is the lead sponsor of 146 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 20 - 45 years
  • Newly diagnosed patients with multiple sclerosis
  • Relapsing-remitting MS (RRMS) or clinically isolated syndrome (CIS)
  • EDSS 0-6
  • Signed informed consent

Exclusion criteria

Exclusion Criteria:

  • Progressive forms of MS (PRMS or SPMS), Malignant MS
  • Non-cooperation, disagreement with the study
  • Contraindication to spiroergometry
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Controlled combined program (aerobic-resistant)

    Patients randomized into the Experimental arm will undergo controlled exercise on a cycling ergometer in combination with strength training on a multifunctional fitness device for 1-hour duration, twice a week for one month, and once a week for the next month (12 therapies in total).

    Procedure: Controlled combined exercise group

  • Active comparator
    Conventional rehabilitation

    Patients randomized into this study arm will undergo conventional rehabilitation.

    Procedure: Conventional rehabilitation

  • No intervention
    No intervention

    Patients randomized into this study arm will undergo no intervention and will serve as the control group.

Interventions

  • ProcedureControlled combined exercise group

    Patients will undergo protocol-defined combined aerobic-resistant therapy on a cycling ergometer and multifunctional fitness device

  • ProcedureConventional rehabilitation

    Patients will undergo conventional rehabilitation.

06

What researchers measure

Primary outcomes

  1. Maximal aerobic capacity (VO2max.kg-1)

    Change after six months follow up in conventional, experimental and control group

    Time frame: 6 months

  2. Power to weight ratio (W.kg-1)

    Change after six months follow up in conventional, experimental and control group

    Time frame: 6 months

Secondary outcomes

  1. Modified Fatigue Impact Scale (MFIS)

    Self-reported measure of level of fatigue, minimum 0 points, maximum 84 points - the less score means less fatigue

    Time frame: 6 months

  2. Symptom-Checklist-90-Standard (SCL-90-S)

    Change in result of percentile score

    Time frame: 6 months

  3. Beck Depression Inventory Score II (BDI II)

    Self-reported rating inventory that measures characteristic attitudes and symptoms of depression, 0-13 - minimal or none depression, 29-63 - severe depression

    Time frame: 6 months

  4. 36-Item Short Form Survey (SF-36)

    Self-reported measure of health-related quality of life, minimum 0 points, maximum 100 points - the higher score is the sign of better quality of life

    Time frame: 6 months

  5. Maximal heart rate (bpm)

    Change after six months follow up in conventional, experimental and control group

    Time frame: 6 months

  6. Heart rate variability (ms)

    Change after six months follow up in conventional, experimental and control group

    Time frame: 6 months

  7. Body composition analysis %)

    Body composition (fat, water, muscle, bone mass) analysis will be performed in study subjects and expressed as per cent.

    Time frame: 6 months

Other outcomes

  1. Cost-benefit analysis of early rehabilitation intervention (CZK)

    Cost-benefit analysis of early rehabilitation intervention will be performed and expressed as the price in Czech crowns (CZK).

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • University Hospital Ostrava
    Ostrava, Moravian-Silesian Region 708 52, Czechia
    • Jiří Hynčica · Contact · jiri.hyncica@fno.cz · 0042059737
    • Anna Šilarová, MD · Principal investigator
    Recruiting
08

References and documents

Publications

  • Razazian N, Kazeminia M, Moayedi H, Daneshkhah A, Shohaimi S, Mohammadi M, Jalali R, Salari N. The impact of physical exercise on the fatigue symptoms in patients with multiple sclerosis: a systematic review and meta-analysis. BMC Neurol. 2020 Mar 13;20(1):93. doi: 10.1186/s12883-020-01654-y. PubMed 32169035 ↗
  • Taul-Madsen L, Connolly L, Dennett R, Freeman J, Dalgas U, Hvid LG. Is Aerobic or Resistance Training the Most Effective Exercise Modality for Improving Lower Extremity Physical Function and Perceived Fatigue in People With Multiple Sclerosis? A Systematic Review and Meta-analysis. Arch Phys Med Rehabil. 2021 Oct;102(10):2032-2048. doi: 10.1016/j.apmr.2021.03.026. Epub 2021 Apr 24. PubMed 33901439 ↗
  • Cruickshank TM, Reyes AR, Ziman MR. A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease. Medicine (Baltimore). 2015 Jan;94(4):e411. doi: 10.1097/MD.0000000000000411. PubMed 25634170 ↗
  • Hansen D, Wens I, Keytsman C, Eijnde BO, Dendale P. Is long-term exercise intervention effective to improve cardiac autonomic control during exercise in subjects with multiple sclerosis? A randomized controlled trial. Eur J Phys Rehabil Med. 2015 Apr;51(2):223-31. Epub 2014 Mar 6. PubMed 24603938 ↗

Individual participant data

Plan to share: No — There is no plan to make individual participant data available to other researchers. The data may be provided upon request.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05671588
Lead sponsor
University Hospital Ostrava
Responsible party
Sponsor
First posted
Jan 4, 2023
Start date
May 1, 2022
Primary completion
Jun 30, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Jan 16, 2024

Study contacts

Jiří Hynčica
Contact
jiri.hyncica@fno.cz
0042059737 ext. 2587
Anna Šilarová, MD
principal investigator · University Hospital Ostrava

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion